2017 annual financial data
Eledon Pharmaceuticals 2017 Operating cash flow growth
Direct answer
Operating cash flow growth was 59.09%.
Operating income was -13,121,000 USD and net income was -13,116,000 USD.
Operating cash flow was -14,941,000 USD.
Get free Eledon Pharmaceuticals email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 0 USD
- Operating income
- -13,121,000 USD
- Net income
- -13,116,000 USD
- Operating cash flow
- -14,941,000 USD